Trial intelligence / Profile preview

Therapeutic vs Prophylactic Enoxaparin for Distal DVT

NCT03805672Phase 4Terminated

Sponsor
Oregon Health & Science University
Start
Sep 2014
Primary completion
Jul 2015
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of enoxaparin in deep vein thrombosis (DVT), sponsored by Oregon Health & Science University. Started Sep 2014; status: terminated.

02

Drugs

enoxaparin
03

Conditions

deep vein thrombosis (DVT)

Beyond the preview

Go deeper on NCT03805672.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03805672.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call